QA: Akebia Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001517022_2024_Akebia_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001517022, Akebia Therapeutics Inc

  xvar xval
0 AssetsCurrent 118,149,000
1 IntangibleAssetsNetIncludingGoodwill 95,086,000
2 PropertyPlantAndEquipmentNet 3,629,000
3 remainder_Assets 24,839,000
4 LiabilitiesCurrent 99,870,000
5 LiabilitiesNoncurrent 78,311,000
6 remainder_Liabilities 94,106,000
7 CostOfGoodsAndServicesSold 72,084,296
8 SellingGeneralAndAdministrativeExpense 55,760,122
9 ResearchAndDevelopmentExpense -39,067,010
10 remainder_Expenses 8,464,203
11 remainder_Revenues 178,513,614
12 remainder_NetIncome -8,230,531
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 241,703,000
1 Liabilities 272,287,000
2 Expenses 97,241,611
3 Revenues 178,513,614
4 StockholdersEquity -30,584,000
5 NetIncome 73,041,472
6 ComprehensiveNetIncome 73,041,472
7 BaseVar 398,987,878
8 EconomicCapitalRatiobeforeLimitedLiability 0.0248
9 EconomicCapitalRatio 1.44

Edgar->Model Mapping

Feature Distribution

Change over Time